Clinical trial
Efficacy of Immunonutrients in Reducing Oral Mucositis in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: A Prospective, Multicenter, Randomized Controlled Clinical Trial
NCT05892354 is registered in ClinicalTrials.gov with First Affiliated Hospital of Guangxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Immunonutrients in Reducing Oral Mucositis in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: A Prospective, Multicenter, Randomized Controlled Clinical Trial
- Lead sponsor
- First Affiliated Hospital of Guangxi Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 12, 2023
- Completion date
- April 1, 2027
- Enrollment
- 190 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced nasopharyngeal carcinoma